Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Akzo Nobel N.V. Patents
Assignee:
Akzo Nobel N.V.
Address:
Arnhem, NL
No. of patents:
1056
Patents:


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next










Patent Number Title Of Patent Date Issued
5851378 Hydrocracking catalyst comprising coated cracking component particles December 22, 1998
The invention relates to a hydrocracking catalyst containing at least one hydrogenation metal component, and particles of a cracking component of which at least 50% of the outer surface is coated with a layer of a pre-formed oxide, which layer has a thickness in the range of 10 nm to 5
5844049 Sulfur-vulcanized rubber compositions comprising substituted succinimide compounds December 1, 1998
Rubber compositions are provided having improved physical properties. More particularly, the present invention relates to sulfur-vulcanized rubber compositions which are vulcanized in the presence of certain bis-succinimide coagents, which possess anti-reversion and/or accelerating p
5843722 Coccidiosis poultry vaccine December 1, 1998
This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used fo
5843454 HIV immunogenic complexes December 1, 1998
A vaccine and a method of raising neutralizing antibodies against HIV infection. The vaccine comprises a complex of gp120 covalently bonded to CD4 or to succinyl concanvalin A. Also disclosed are immunological tests using the complex or antibody thereto for detection of HIV infection.
5843449 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune dise December 1, 1998
The present invention relates to novel peptides derived from the autoantigen HC gp-39, said peptides comprising at least one of the amino acid sequences FGRSFTILAS (SEQ ID No. 1), FTLASSETG (SEQ ID No. 2), YDDQESVKS (SEQ ID No. 3) and FSKIASNTQ (SEQ ID No. 4). The peptides resemble M
5843405 Epstein-Barr virus peptides and antibodies against these peptides December 1, 1998
The invention relates to peptides or fragments thereof which are immunochemically reactive with Epstein-Barr Virus (EBV) antibodies. New antibodies directed to said peptides or fragments thereof are also part of the invention.The invention also relates to a method for the detection of EB
5837864 Method for producing a suspension in water of a cellulose ether, and dry mixture suitable for us November 17, 1998
In a method of producing a suspension of a nonionic cellulose ether that has no turbidity point, the water forming part of the suspension is mixed with a dry mixture containing a cellulose ether, which is cross-linked with glyoxal, and an electrolyte salt. This electrolyte salt consists
5837501 Nucleic acid quantitation by co-amplification of target with multiple internal controls November 17, 1998
The present invention is related to an improved method for the quantification of nucleic acid, which can be performed with a minimal amount of nucleic acid amplification reactions. The method according to the invention for the quantification of analyte nucleic acid in a sample compri
5834255 Quantification of nucleic acid November 10, 1998
Disclosed is a method of quantifying a target nucleic acid in a test sample by adding to the test sample a known number of molecules of a corresponding nucleic acid comprising a well-defined mutant sequence. Said mutant sequence being discriminatory from the target nucleic acid. Subs
5833886 Thermostability enhancement of polyphosphate flame retardants November 10, 1998
The thermostability of an aromatic polyphosphate composition an be improved by the addition of an effective amount of a hydroxy-terminated aromatic polyphosphate composition for such.
5831109 Polyalkylaluminoxane compositions formed by non-hydrolytic means November 3, 1998
The present invention relates to a process which comprises the non-hydrolytic transformation of an aluminoxane precursor composition, comprising carbon-to-oxygen bonds which can be alkylated by an alkylaluminum moiety, into a catalytically useful aluminoxane composition. In one embod
5830681 Immunoassays for and monoclonal antibodies to prothrombin activation peptide F1.2 November 3, 1998
Monoclonal antibodies and fragments thereof, with binding specificity for an epitope on the carboxy terminus of prothrombin activation peptide F1.2, which can be used in immunoassays to predict thrombosis by measuring the extent of activation of prothrombin. These monoclonal antibodies a
5827646 Diagnostic reagents for the detection of antibodies to EBV October 27, 1998
The present invention is directed to diagnostic reagents for the detection of antibodies against the Epstein Barr Virus and a method for the detection of antibodies to the Epstein Barr Virus in a sample.The diagnostic reagents according to the invention comprise a combination of at least
5824832 Linear alxylbenzene formation using low temperature ionic liquid October 20, 1998
A low temperature molten ionic liquid composition comprising a mixture of a metal halide and an alkyl-containing amine hydrohalide salt can be used in linear alkylbenzene formation. The metal halide is a covalently bonded metal halide which can contain a metal selected from the group com
5821317 Adduct of bisepoxy compound and P guanamine October 13, 1998
The invention pertains to an adduct obtainable by condensation of a bisepoxy compound and a P-guanamine according to the formula ##STR1## wherein X is CR.sub.3 R.sub.4 --(CR.sub.1 R.sub.2).sub.n --CR.sub.5 R.sub.6 or o-phenylidene, n is 0 or 1, and R.sub.1 -R.sub.8 may be the sam
5821305 Allyl-containing epoxy resin composition comprising a copolymer of an ethylenically unsaturated October 13, 1998
The invention relates to a resin composition comprising epoxy resin, a cross linking agent for the epoxy resin in the form of a carboxylic anhydride, and at least one allyl network forming compound. According to the invention, the anhydride-functional compound is a copolymer of an et
5820806 Process for the preparation of polyketone fibers October 13, 1998
It has been found that fibres can be spun in a simple manner from polyketone polymer solutions by making a thermoreversible gel from a solution of polyketone and a solvent for the polymer having a boiling temperature above 443 K, a melting temperature below 373 K, and a polymer disso
5817857 (4-Hydroxy-alkylphenyl diphenyl phosphate flame rerardants October 6, 1998
The present invention is a process for forming monohydroxy-terminated aromatic oligomeric phosphates by the reaction of a diaryl halophosphate, such as diphenyl chlorophosphate, optionally in the presence of some monoaryl dihalophosphate, with an aromatic diol, such as resorcinol, to
5817801 Cellulose solutions and products made therefrom October 6, 1998
An optically anisotropic solution containing cellulose and inorganic acids of phosphorus contains 94-100 wt % of the following constituents: cellulose; phosphoric acid and/or its anhydrides; and water; and 0-6 wt % of other constituents. This solution can be prepared in an apparatus in
5814320 Eimeria tenella polypeptide and vaccine containing same September 29, 1998
The invention is concerned with a protein having the immunological properties of Eimeria tenella which is reactive with a monoclonal antibody E. TEN 11P-2 raised against E. tenella sporozoites.The invention also relates to polypeptide fragments of this protein which can be used for immun
5814275 Obstruction detector for a fluid flow line of a medical laboratory instrument September 29, 1998
An apparatus for detecting obstructions of a flow line. A detector housing is provided having a cavity therein. The detector housing has first and second openings into the cavity. The flow line is attached to the detector housing establishing a flow path through the first opening, the ca
5811103 Hog cholera virus vaccine and diagnostic September 22, 1998
The present invention is concerned with a hog cholera virus vaccine comprising a polypeptide characteristic of hog cholera virus. Vector vaccines capable to express a nucleic acid sequence encoding such a polypeptide also form part of the present invention. Said polypeptide and nucle
5808110 Cyclic ketone peroxide formulations September 15, 1998
A transportable, storage stable cyclic ketone peroxide composition which comprises 1.0-90% by weight of one or more cyclic ketone peroxides and 10-99% by weight of one or more diluents selected from the group consisting of liquid phlegmatizers for the cyclic ketone peroxides, plastic
5807534 In vivo binding pair pretargeting September 15, 1998
A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a
5804199 Oil-based and water-based adjuvant mixture September 8, 1998
The invention relates to a vaccine comprising an antigenic substance and a mixture of two adjuvants wherein one adjuvant is oil-based whereas the other adjuvant is water-based.
5804120 Process for making cellulose extrudates September 8, 1998
Celluloe extrudates can be made from an optically anisotropic solution containing 94-100 wt % of: cellulose; phosphoric acid and/or its anhydrides; and water by extruding the solution, coagulating the formed extrudates, and then aftertreating those extrudates so that they have a degr
5795773 Device for detecting microorganisms August 18, 1998
A method and a sealable, sterilizable vessel for detecting the presence of microorganisms in a specimen, the vessel containing a liquid culture medium and a sensor with an indicator medium therein. A gas permeable membrane with a gas impermeable removable seal thereon are provided in a
5795741 Coccidiosis poultry vaccine August 18, 1998
This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used fo
5792644 DNA encoding an Eimeria 200 kd antigen August 11, 1998
The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be
5789528 Process for the preparation of polyesters and copolyesters August 4, 1998
The preparation of polyesters and copolyesters, titanium dioxide precipitates and/or titanium dioxide/silicon dioxide coprecipitates having a composition of TiO.sub.2 :SiO.sub.2 >90:10 mol/mol and/or titanium dioxide/zirconium dioxide coprecipitates having a composition of TiO.sub.2
5789388 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity August 4, 1998
The present invention relates to a vaccine against a virus associated with antibody-dependent-enhancement of viral infectivity. Such a vaccine comprises a herpesvirus vector which is able to spread from cell-to-cell and which does produce non-infectious progeny virions having a gene
5789233 DNA encoding an Eimekia 50 KD antigen August 4, 1998
The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be
5787901 Method for the measurement of blood coagulation properties with absorbent materials August 4, 1998
A point-of-care device allows for a simple and rapid determination of blood coagulation properties. The device is comprised of an absorbent material and a clotting agent. In operation, a quantity of blood is first allowed to clot, after which remaining serum is allowed to migrate through
5783730 Formation of styrene phosphonic acid July 21, 1998
Styrene phosphonic acid (SPA) can be formed the reaction of phosphorous acid with acetophenone, preferably in the presence of a Lewis acid catalyst, to form a hydroxy adduct intermediate thereof which is then reacted with acetic anhydride to form the acyl derivative of the hydroxy ad
5783197 Eimeria polypeptide antigen and vaccines containing the same July 21, 1998
The present invention is concerned with a polypeptide of Eimeria which can be used for the immunization of poultry against coccidiosis. Furthermore, the invention comprises a DNA fragment of Eimeria coding for said polypeptide.
5783192 Recombinant feline herpesvirus vaccine July 21, 1998
The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome.The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived f
5780298 DNA encoding the sn-RNP-A antigen and fragments thereof July 14, 1998
The present invention relates to a DNA encoding the human U.sub.1 -snRNP-A protein antigen, wherein said protein antigen is reactive towards an auto-antibody which is associated with an auto-immune disease, and the use of this protein in diagnostic tests relating to auto-immune diseases.
5780289 Coccidiosis poultry vaccine DNA encoding an elmeria 20K antigen July 14, 1998
The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be
5779834 Process of making a shoe with a spray-molded sole and shoe manufactured therefrom July 14, 1998
A process of making a shoe includes bonding a flat structure to an upper layer of the shoe to form a bonded structure. The flat structure has a melting temperature T.sub.2 and provides stability to a shape of the upper layer. The bonded structure is positioned into a mold so that an unde
5779815 Process for removal of lumen fillers and other soluble residues from hollow filaments July 14, 1998
A process and an apparatus for removal of a lumen filler and/or other soluble residues from hollow filament bundles are described. The hollow filament bundles are first roughly cleaned by centrifuging, after which in a process preferably containing multiple steps they are cleaned by
5777143 Hydrocarbon soluble alkylaluminoxane compositions formed by use of non-hydrolytic means July 7, 1998
A hydrocarbon-soluble alkylaluminoxane composition, such as, methylaluminoxane or even a modified methylaluminoxane, can be prepared by preparing an alkylaluminoxane precursor via non-hydrolytic means, such as, by treating at least one trialkylaluminum compound with a compound contai
5777090 Carboxymethyl inulin July 7, 1998
Disclosed is carboxymethyl inulin having a degree of substitution (DS) ranging from 0,15 to 2,5, preferably from 0,5 to 1,5, a process for the preparation of said carboxymethyl inulin by reacting inulin at a concentration of at least 100 g/l, preferably at least 200 g/l, at elevated
5776375 Electro-optical device stable in the 600-1600 nanometer wavelength range July 7, 1998
The present invention provides an electro-optical device comprising NLO polymer in the active layer with improved stability for light in the wavelength range of 600-1600 nm is guided through the device. The present invention is directed to an electro-optical device comprising two claddin
5776354 Use of a porous, particulate material in a packed filter bed for liquid/gas and/or liquid/liquid July 7, 1998
A method for the use of a porous, preferably dimensionally stable, particulate material in a packed filter bed for separating a disperse liquid phase from a gas and/or separating a disperse liquid phase from a liquid, with the average size of the particles being in the range of from
5773605 Sulfated glycosaminoglycanoid derivatives of the heparin sulfate type June 30, 1998
The invention relates to sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type, of which N-sulfate, N-acetate, and hydroxy groups, are replaced by alkoxy, aryloxy, aralkoxy, or O-sulfate groups. The compounds have antithrombotic and smooth muscle cell prol
5770360 Elimination of false negatives in nucleic acid detection June 23, 1998
The present invention relates to a method for the elimination of false negative test results in assays for the detection of amplified analyte nucleic acid in a sample. Prior to amplification, an internal control is added to the sample, comprising a nucleic acid distinguishable from the
5766908 High-flux semipermeable membrane containing immobilized affinity ligands June 16, 1998
An affinity support is provided containing a high flux semipermeable hydrogel membrane surface-modified with an affinity ligand, such as a protein which may be an antibody or enzyme, or a cell receptor complement, useful for affinity separation of biological macromolecules, including
5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. June 16, 1998
A novel cell line chronically infected with HIV-2.sub.NIHZ virus secretes the precursor of the viral envelope proteins in extracellular medium. The cells grow well in serum-free medium which enables the concentration of the conditioned medium of the cells to be greatly increased (>100
5764820 Method of forming integrated electro-optical device containing polymeric waveguide and semicondu June 9, 1998
The invention relates to a method of fabricating an electro-optical device which comprises integrating a semiconductor component with a polymeric optical waveguide component. According to the invention, a semiconductor component obtained by epitaxial lift-off (ELO) is embedded in a waveg
5760859 Retardation layer having a dispersion adapted to the active liquid-crystalline cell June 2, 1998
The invention is in the field of retardation layers comprising high-molecular weight liquid-crystalline material for liquid-crystalline displays. The invention is directed to a retardation layer for a liquid-crystalline display comprising high-molecular weight liquid-crystalline mate
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next

 
 
  Recently Added Patents
Method for assembling a camera module, and camera module
Method for building taxonomy of topics and categorizing videos
Handheld electronic device with text disambiguation employing advanced editing feature
Efficient paging in a wireless communication system
Device for maneuvering a vehicle using maneuvering moves using at least one trajectory
Phosphonate compounds
Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications
  Randomly Featured Patents
Mower with lever actuated drive control
Phosphor and method for producing same, and light-emitting device using same and method for manufacturing such device
Apparatus and method whereby wave energy is correlated with geometry of a manufactured part or the like or to positional relationships in a system
Thin printable electrochemical cell and methods of making the same
Convertible plaque
Hub with locking mechanism
Resonant gauge with microbeam driven in constant electric field
Credenza
Controller
Aquarium cover